Brief: Adocia and Lilly announce successful completion of an insulin pump study with BioChaperone Lispro in people with type 1 diabetes

Adocia SA

16/12/2016 17:01

Dec 16 (Reuters) - Eli Lilly And Co  LLY.N : 
    * Adocia and Lilly announce successful completion of an 
insulin pump study with Biochaperone Lispro in people with Type 
1 diabetes 
    * Biochaperone Lispro U100 and Humalog showed similar safety 
results and were well tolerated 
    * An accelerated absorption profile of Biochaperone Lispro 
U100 was observed across three insulin delivery devices tested 
    * Biochaperone Lispro U100 demonstrated statistically 
significant increase in insulin exposure 
    * Biochaperone Lispro was associated with a consistent 
pattern of improved response to mixed meal testing compared to 
Humalog 
    * Both Biochaperone Lispro and Humalog were similarly well 
tolerated 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBwB4T8pa 
Further company coverage:  LLY.N  
 
 (Bengaluru Newsroom: +91 806 749 1136)